Injective Protocol is receiving attention as daily active addresses have surged tenfold since January 2025. Although INJ prices are currently steady, the imminent release of the EVM testnet could potentially push the price above $12.

In the second quarter of 2025, Injective Protocol, a layer-1 blockchain tailored for decentralized finance (DeFi), saw its total value locked (TVL) increase from around $20 million in April to $33 million by July, yet the INJ price has not experienced significant increases.

Will Injective Crypto Break $12?

Investors are eager to see if the recent developments of Injective, such as the launch of the EVM testnet and a focus on real-world asset (RWA) tokenization, will drive INJ above $12, surpassing a local resistance level.

Market analysis shows that INJ has been trading within a narrow $3 range, fluctuating between $9 and $12. To give bulls a chance to gain momentum, a breakout with high volume above the $12 threshold is needed, which could see INJ target $14, retesting previous highs from Q2 2025.

Despite muted price movements, on-chain data suggests a bullish sentiment. As per Artemis data, daily active addresses on the Injective network have significantly increased nearly tenfold over the past six months, rising from 5,000 to over 81,000 by early July 2025.

Injective EVM Testnet Released

The surge in network activity coincides with Injective’s technological progress. Unlike Ethereum, it boasts the ability to handle 20,000 transactions per second, featuring near-zero fees and immediate transaction confirmations.

This advanced infrastructure, which also supports interoperability across Ethereum, Cosmos, and non-EVM chains like Solana, bolsters Injective’s appeal as a DeFi platform. The recent launch of the Injective EVM testnet on July 2, 2025, marks a significant step forward, allowing Ethereum-compatible smart contracts to function seamlessly without needing external bridges.

Focus on RWA Tokenization

This upgrade is pivotal as Injective aims to capture market share in the rapidly growing tokenization sector, positioning itself as one of the premier cryptos to buy. Currently, Helix, the leading DeFi application on Injective, enables trading of over 25 tokenized assets, including stocks like Apple and Tesla, as well as commodities like gold and silver.

Moreover, strategic collaborations with major players such as BlackRock and Google Cloud further solidify their objectives in the tokenization space.